BACKGROUND: Chest wall sarcomas are rare and pose significant technical challenges in surgical management, particularly in patients with advanced disease. In this study, we examined the extent of resection, reconstruction techniques, and oncological outcomes of patients with chest wall soft tissue and bone sarcomas. METHODS: This retrospective single-center series included patients who underwent surgery at our center between May 2014 and February 2022 for deep-seated/subfascial primary and recurrent soft tissue or bone sarcomas of the chest wall requiring significant resection and extensive reconstruction. We analyzed clinical and operative data, including extent of resection, reconstruction techniques, and oncological outcomes. Additionally, we compared survival outcomes between patients with primary and recurrent tumors, and examined how these were influenced by clinical factors using Cox proportional hazards regression analysis. RESULTS: Of the 38 patients included, 22 were treated for primary or recurrent soft tissue sarcoma (STS) and 16 for bone sarcoma. En bloc microscopic radical resection (R0) was achieved in 95.45% and 93.75% of patients with soft tissue and bone sarcomas, respectively. Nonetheless, local recurrence or distant metastases occurred in 40%, 58.33%, and 40% of patients with primary soft tissue, recurrent soft tissue, and bone sarcomas, respectively. Adherence to clinical guidelines and treatment in the reference center was high for bone sarcoma (93.75%), but notably low for STS, resulting in 54.55% of these patients requiring re-resection. Compared with those who underwent only one surgery, patients who underwent re-resection had poorer postoperative outcomes, more severe complications, and longer hospital stay. CONCLUSIONS: Chest wall sarcomas often require extensive resection and complex reconstruction. Although surgical treatment at reference sarcoma centers has significantly improved oncological and clinical outcomes, the prognosis of these patients remains guarded, necessitating further related research and continued refinement in surgical techniques, adjuvant therapies, and follow-up strategies.

3rd Department of Surgery 1st Faculty of Medicine Charles University and Motol University Hospital Prague Czech Republic

Department of Immunology 2nd Faculty of Medicine Charles University and Motol University Hospital Prague Czech Republic

Zobrazit více v PubMed

Gatta G, Capocaccia R, Botta L, et al. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. Lancet Oncol 2017;18:1022-39. 10.1016/S1470-2045(17)30445-X PubMed DOI

WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. Volume 3. 5th edition. Lyon: IARC; 2020. Accessed May 1, 2021. Available online: https://publications.iarc.fr/588

Blay JY, Honoré C, Stoeckle E, et al. Surgery in reference centers improves survival of sarcoma patients: a nationwide study. Ann Oncol 2019;30:1143-53. 10.1093/annonc/mdz124 PubMed DOI PMC

Keung EZ, Chiang YJ, Cormier JN, et al. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma. Cancer 2018;124:4495-503. 10.1002/cncr.31699 PubMed DOI PMC

Kamarajah SK, Baia M, Naumann DN, et al. Association between centre volume and allocation to curative surgery and long-term survival for retroperitoneal sarcoma. BJS Open 2023;7:zrad059. 10.1093/bjsopen/zrad059 PubMed DOI PMC

Gronchi A, Miah AB, Dei Tos AP, et al. Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2021;32:1348-65. 10.1016/j.annonc.2021.07.006 PubMed DOI

Thakur S, Choong E, Balasooriya A, et al. Surgical resection of chest wall sarcomas: an analysis of survival and predictors of outcome at an Australian multidisciplinary sarcoma service. ANZ J Surg 2022;92:2613-9. 10.1111/ans.17904 PubMed DOI

Mesko NW, Bribriesco AC, Raymond DP. Surgical Management of Chest Wall Sarcoma. Surg Oncol Clin N Am 2020;29:655-72. 10.1016/j.soc.2020.06.008 PubMed DOI

Moulin B, Messiou C, Crombe A, et al. Diagnosis strategy of adipocytic soft-tissue tumors in adults: a consensus from European experts. Eur J Surg Oncol 2022;48:518-25. 10.1016/j.ejso.2021.10.009 PubMed DOI

Trojani M, Contesso G, Coindre JM, et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984;33:37-42. 10.1002/ijc.2910330108 PubMed DOI

Brennan B, Kirton L, Marec-Bérard P, et al. Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial. Lancet 2022;400:1513-21. 10.1016/S0140-6736(22)01790-1 PubMed DOI

Banuelos J, Abu-Ghname A, Bite U, et al. Reconstruction of Oncologic Sternectomy Defects: Lessons Learned from 60 Cases at a Single Institution. Plast Reconstr Surg Glob Open 2019;7:e2351. 10.1097/GOX.0000000000002351 PubMed DOI PMC

Crago AM, Cardona K, Koseła-Paterczyk H, et al. Management of Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma. Surg Oncol Clin N Am 2022;31:419-30. 10.1016/j.soc.2022.03.006 PubMed DOI PMC

Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009;250:187-96. 10.1097/SLA.0b013e3181b13ca2 PubMed DOI

Stacchiotti S, Frezza AM, Blay JY, et al. Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities. Cancer 2021;127:2934-42. 10.1002/cncr.33618 PubMed DOI PMC

Blay JY, Penel N, Valentin T, et al. Improved nationwide survival of sarcoma patients with a network of reference centers. Ann Oncol 2024;35:351-63. 10.1016/j.annonc.2024.01.001 PubMed DOI

van Roozendaal LM, Bosmans JWAM, Daemen JHT, et al. Management of soft tissue sarcomas of the chest wall: a comprehensive overview. J Thorac Dis 2024;16:3484-92. 10.21037/jtd-23-1149 PubMed DOI PMC

Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 1980;(153):106-20. PubMed

Bonvalot S, Miceli R, Berselli M, et al. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control. Ann Surg Oncol 2010;17:1507-14. 10.1245/s10434-010-1057-5 PubMed DOI

Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol 2009;27:24-30. 10.1200/JCO.2008.17.8871 PubMed DOI

Ozaniak A, Hladik P, Lischke R. Successful Restoration of Elbow Extension Using the Latissimus Dorsi Flap: Case Report. Plast Reconstr Surg Glob Open 2022;10:e4121. 10.1097/GOX.0000000000004121 PubMed DOI PMC

Dadras M, Koepp P, Wagner JM, et al. Antibiotic prophylaxis for prevention of wound infections after soft tissue sarcoma resection: A retrospective cohort study. J Surg Oncol 2020;122:1685-92. 10.1002/jso.26188 PubMed DOI

Bergovec M, Smolle M, Lindenmann J, et al. High complication rate with titanium plates for chest wall reconstruction following tumour resection. Eur J Cardiothorac Surg 2022;62:ezac534. 10.1093/ejcts/ezac534 PubMed DOI

Collaud S, Stork T, Dirksen U, et al. Surgical Treatment for Primary Chest Wall Sarcoma: A Single-Institution Study. J Surg Res 2021;260:149-54. 10.1016/j.jss.2020.11.078 PubMed DOI

Casali PG, Bielack S, Abecassis N, et al. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2018;29:iv79-95. 10.1093/annonc/mdy310 PubMed DOI

O'Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 2002;359:2235-41. 10.1016/S0140-6736(02)09292-9 PubMed DOI

Beane JD, Yang JC, White D, et al. Efficacy of adjuvant radiation therapy in the treatment of soft tissue sarcoma of the extremity: 20-year follow-up of a randomized prospective trial. Ann Surg Oncol 2014;21:2484-9. 10.1245/s10434-014-3732-4 PubMed DOI PMC

Dagan R, Indelicato DJ, McGee L, et al. The significance of a marginal excision after preoperative radiation therapy for soft tissue sarcoma of the extremity. Cancer 2012;118:3199-207. 10.1002/cncr.26489 PubMed DOI

Woll PJ, Reichardt P, Le Cesne A, et al. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncol 2012;13:1045-54. 10.1016/S1470-2045(12)70346-7 PubMed DOI

Roulleaux Dugage M, Nassif EF, Italiano A, et al. Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A Biomarker Driven and Histotype Tailored Review. Front Immunol 2021;12:775761. 10.3389/fimmu.2021.775761 PubMed DOI PMC

Fazel M, Dufresne A, Vanacker H, et al. Immunotherapy for Soft Tissue Sarcomas: Anti-PD1/PDL1 and Beyond. Cancers (Basel) 2023;15:1643. 10.3390/cancers15061643 PubMed DOI PMC